{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:48:50Z","timestamp":1793119730833,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.vaccine.2023.08.073","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T09:12:51Z","timestamp":1693386771000},"page":"5957-5964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pertussis immunisation strategies to optimise infant pertussis control: A narrative systematic review"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2712-7971","authenticated-orcid":false,"given":"Elise","family":"Tessier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Newport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie G.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna A.","family":"Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yun Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saran","family":"Shantikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri","family":"Amirthalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Todkill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.08.073_b0005","unstructured":"World Health Organization. Pertussis vaccines: WHO position paper \u2013 August 2015; 2015."},{"issue":"40","key":"10.1016\/j.vaccine.2023.08.073_b0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2807\/1560-7917.ES2014.19.40.20921","article-title":"Epidemiology of pertussis in Italy: disease trends over the last century","volume":"19","author":"Gonfiantini","year":"2014","journal-title":"Eurosurveillance"},{"issue":"11","key":"10.1016\/j.vaccine.2023.08.073_b0015","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamapediatrics.2013.2353","article-title":"Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age","volume":"167","author":"Glanz","year":"2013","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.073_b0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3201\/eid1801.110784","article-title":"Accelerating control of pertussis in England and Wales","volume":"18","author":"Campbell","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.073_b0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1086\/341027","article-title":"Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany","volume":"35","author":"Juretzko","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"42","key":"10.1016\/j.vaccine.2023.08.073_b0030","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1016\/j.vaccine.2009.07.092","article-title":"Control of pertussis-Lessons learnt from a 10-year surveillance programme in Sweden","volume":"27","author":"Carlsson","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.073_b0035","doi-asserted-by":"crossref","unstructured":"Zumstein J, Heininger U, Swiss Paediat Surveillance U, S P. Decline of pertussis in hospitalised children following the introduction of immunisation in pregnancy - results from a nationwide, prospective surveillance study, 2013-2020. Swiss Med Weekly 2021;151:10.","DOI":"10.4414\/SMW.2021.w30064"},{"key":"10.1016\/j.vaccine.2023.08.073_b0040","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. Dutch National Immunisation Programme; 2019. Available from: https:\/\/rijksvaccinatieprogramma.nl\/english."},{"key":"10.1016\/j.vaccine.2023.08.073_b0045","unstructured":"National Institute for Health Research. PROSPERO International prospective register for systematic reviews; 2022. Available from: https:\/\/www.crd.york.ac.uk\/PROSPERO\/."},{"key":"10.1016\/j.vaccine.2023.08.073_b0050","unstructured":"Thomas J, Graziosi S, Brunton J, Ghouze Z, O'Driscoll P, Bond M, et al. EPPI-reviewer: advanced software for systematic reviews, maps and evidence synthesis; 2022."},{"key":"10.1016\/j.vaccine.2023.08.073_b0055","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2023.08.073_b0060","unstructured":"PRISMA. PRISMA transparent reporting of systematic reviews and meta-analyses; 2022. Available from: http:\/\/www.prisma-statement.org\/."},{"issue":"17","key":"10.1016\/j.vaccine.2023.08.073_b0065","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.17.2100515","article-title":"Pertussis surveillance results from a French general practitioner network, France, 2017 to 2020","volume":"27","author":"Debin","year":"2022","journal-title":"Eurosurveillance"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.073_b0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1473-3099(21)00267-X","article-title":"Effect of change in vaccine schedule on pertussis epidemiology in France: a modelling and serological study","volume":"22","author":"Paireau","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"43","key":"10.1016\/j.vaccine.2023.08.073_b0075","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1016\/j.vaccine.2015.09.025","article-title":"Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies","volume":"33","author":"Campbell","year":"2015","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2023.08.073_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16224531","article-title":"Trends in hospital admissions for pertussis infection: a nationwide retrospective observational study in Italy, 2002\u20132016","volume":"16","author":"Fiasca","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"1416","key":"10.1016\/j.vaccine.2023.08.073_b0085","first-page":"21","article-title":"Whooping cough-where are we now? A review","volume":"128","author":"Kiedrzynski","year":"2015","journal-title":"New Zeal Med J"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.073_b0090","first-page":"1154","article-title":"Epidemiological study of pertussis immunization effectiveness in varna region (2009\u20132014)","volume":"22","author":"Tsankova","year":"2016","journal-title":"J IMAB - Annu Proc (Sci Pap)"},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.073_b0095","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1440-1754.2007.01034.x","article-title":"Hospitalisations due to pertussis in New Zealand in the pre-immunisation and mass immunisation eras","volume":"43","author":"Somerville","year":"2007","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2023.08.073_b0100","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268820000102","article-title":"Evaluation of immunisation strategies for pertussis vaccines in Jinan, China - an interrupted time-series study","volume":"148","author":"Liu","year":"2020","journal-title":"Epidemiol Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2023.08.073_b0105","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1080\/21645515.2020.1806673","article-title":"Pertussis in Italy: how to protect the \u201cunprotectable\u201d?","volume":"17","author":"Fiasca","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.073_b0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/INF.0b013e3181f43906","article-title":"Severe pertussis in infants estimate impact of first vaccine dose at 6 verusis 8 weeks in Australia","volume":"30","author":"Foxwell","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2023.08.073_b0115","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1542\/peds.2007-3025","article-title":"Potential impact of acceleration of the pertussis vaccine primary series for infants","volume":"122","author":"Shinall","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.073_b0120","doi-asserted-by":"crossref","first-page":"E513","DOI":"10.1542\/peds.2013-3181","article-title":"Duration of protection after first dose of acellular pertussis vaccine in infants","volume":"133","author":"Quinn","year":"2014","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.073_b0125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/ije\/dyac175","article-title":"Estimating the excess burden of pertussis disease in Australia within the first year of life, that might have been prevented through timely vaccination","volume":"52","author":"Jayasundara","year":"2023","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2023.08.073_b0130","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1093\/cid\/ciw559","article-title":"Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction","volume":"63","author":"Amirthalingam","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.073_b0135","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/21645515.2020.1764826","article-title":"Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV\/Hib vaccine","volume":"17","author":"Bayliss","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.073_b0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/cid\/ciu273","article-title":"Pertussis vaccine performance in an epidemic year-Oregon, 2012","volume":"59","author":"Liko","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.073_b0145","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.vaccine.2019.11.069","article-title":"Dose-dependent effectiveness of acellular pertussis vaccine in infants: a population-based case-control study","volume":"38","author":"Mack","year":"2020","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2023.08.073_b0150","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.vaccine.2021.10.013","article-title":"Pertussis burden and acellular pertussis vaccine effectiveness in high risk children","volume":"40","author":"Sheridan","year":"2022","journal-title":"Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2023.08.073_b0155","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0264-410X(02)00777-6","article-title":"Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine","volume":"21","author":"Olin","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.073_b0160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1017\/S0950268808000708","article-title":"Effectiveness of an acellular pertussis vaccine in Japanese children during a non-epidemic period: a matched case-control study","volume":"137","author":"Okada","year":"2009","journal-title":"Epidemiol Infect"},{"issue":"19","key":"10.1016\/j.vaccine.2023.08.073_b0165","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.vaccine.2019.02.047","article-title":"Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009\u20132015","volume":"37","author":"Crowcroft","year":"2019","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2023.08.073_b0170","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1016\/j.vaccine.2020.09.016","article-title":"Brand-specific rates of pertussis disease among Wisconsin children given 1\u20134 doses of pertussis Vaccine, 2010\u20132014","volume":"38","author":"Conway","year":"2020","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2023.08.073_b0175","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/cid\/cix421","article-title":"Reduced severity of pertussis in persons with age-appropriate pertussis vaccination-United States, 2010\u20132012 milder pertussis in vaccinated people","volume":"65","author":"McNamara","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2023.08.073_b0180","doi-asserted-by":"crossref","first-page":"e850","DOI":"10.1016\/j.ijid.2012.07.012","article-title":"National pertussis surveillance in South Korea 1955\u20132011: epidemiological and clinical trends","volume":"16","author":"Choe","year":"2012","journal-title":"Int J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2023.08.073_b0185","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.19118","article-title":"Association of diphtheria-tetanus-acellular pertussis vaccine timeliness and number of doses with age-specific pertussis risk in infants and young children","volume":"4","author":"Rane","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.073_b0190","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.inf.0000116023.56344.46","article-title":"National study of infants hospitalized with pertussis in the acellular vaccine era","volume":"23","author":"Elliott","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.073_b0195","doi-asserted-by":"crossref","first-page":"667","DOI":"10.4161\/hv.23263","article-title":"Surveillance of hospitalized and outpatient cases of pertussis in Catalonia from 2003 to 2009","volume":"9","author":"Fernandez","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.073_b0200","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.inf.0000435503.44620.74","article-title":"Prospective nationwide surveillance of hospitalizations due to pertussis in children, 2006\u20132010","volume":"33","author":"Heininger","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2023.08.073_b0205","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1017\/S0950268811002044","article-title":"The incidence of pertussis hospitalizations among Japanese infants: excess hospitalizations and complications?","volume":"140","author":"Takeuchi","year":"2012","journal-title":"Epidemiol Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2023.08.073_b0210","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3973","article-title":"Pertussis vaccine effectiveness in the setting of pertactin-deficient pertussis","volume":"137","author":"Breakwell","year":"2016","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.073_b0215","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jamapediatrics.2019.0711","article-title":"Duration of immunity and effectiveness of diphtheria-tetanus-acellular pertussis vaccines in children","volume":"173","author":"de Celles","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"5","key":"10.1016\/j.vaccine.2023.08.073_b0220","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy082","article-title":"On the role of different age groups and pertussis vaccines during the 2012 outbreak in Wisconsin","volume":"5","author":"Goldstein","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.073_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2015.11.029","article-title":"Changing patterns of pertussis in a children's hospital in the polymerase chain reaction diagnostic era","volume":"170","author":"Hale","year":"2016","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.vaccine.2023.08.073_b0230","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/INF.0000000000000654","article-title":"Effectiveness of routine and booster pertussis vaccination in children and adolescents, federal state of Brandenburg, Germany, 2002\u20132012","volume":"34","author":"Haller","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2023.08.073_b0235","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.vaccine.2003.11.053","article-title":"Using computer simulations to compare pertussis vaccination strategies in Australia","volume":"22","author":"Hethcote","year":"2004","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2023.08.073_b0240","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJMoa1200850","article-title":"Waning protection after fifth dose of acellular pertussis vaccine in children","volume":"367","author":"Klein","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.vaccine.2023.08.073_b0245","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.vaccine.2018.01.070","article-title":"Effectiveness of acellular pertussis vaccine and evolution of pertussis incidence in the community of Madrid from 1998 to 2015","volume":"36","author":"Latasa","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.073_b0250","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.vaccine.2016.11.004","article-title":"Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand","volume":"35","author":"Radke","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.073_b0255","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-017-4468-4","article-title":"Epidemiology of pertussis in Alberta, Canada 2004\u20132015","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Public Health"},{"issue":"41","key":"10.1016\/j.vaccine.2023.08.073_b0260","first-page":"6144","article-title":"Durability of protection after 5 doses of acellular pertussis vaccine among 5\u20139 year old children in King County","volume":"39","author":"Rane","year":"2021","journal-title":"Washington Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.073_b0265","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/cid\/ciy889","article-title":"Severe pertussis infections in the United States, 2011\u20132015","volume":"69","author":"Mbayei","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.073_b0270","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5694\/mja13.11069","article-title":"Acellular pertussis vaccine effectiveness for children during the 2009\u20132010 pertussis epidemic in Queensland","volume":"200","author":"Sheridan","year":"2014","journal-title":"Med J Aust"},{"issue":"10","key":"10.1016\/j.vaccine.2023.08.073_b0275","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/cid\/ciy757","article-title":"The epidemiology of nationally reported pertussis in the United States, 2000\u20132016","volume":"68","author":"Skoff","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2023.08.073_b0280","doi-asserted-by":"crossref","first-page":"E1047","DOI":"10.1542\/peds.2012-1928","article-title":"Waning immunity to pertussis following 5 doses of DTaP","volume":"131","author":"Tartof","year":"2013","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.073_b0285","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/INF.0000000000002234","article-title":"Pertussis morbidity in children 12\u201359 months of age a NSW public health network study","volume":"38","author":"Staff","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.073_b0290","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3466","article-title":"Acellular pertussis vaccine effectiveness over time","volume":"144","author":"Zerbo","year":"2019","journal-title":"Pediatrics"},{"issue":"30","key":"10.1016\/j.vaccine.2023.08.073_b0295","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1016\/j.vaccine.2019.05.067","article-title":"Acellular pertussis vaccine effectiveness and waning immunity in Alberta, Canada: 2010\u20132015, a Canadian Immunization Research Network (CIRN) study","volume":"37","author":"Bell","year":"2019","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.073_b0300","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.6.21032","article-title":"Surveillance of infant pertussis in Sweden 1998\u20132012; severity of disease in relation to the national vaccination programme","volume":"20","author":"Carlsson","year":"2015","journal-title":"Eurosurveillance"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2023.08.073_b0305","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1016\/j.vaccine.2004.03.046","article-title":"Impact of routine vaccination with a pertussis toxoid vaccine in Denmark","volume":"22","author":"Hviid","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.073_b0310","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vaccine.2020.11.035","article-title":"Effectiveness of four doses of pertussis vaccine during infancy diminished in elementary school age: a test-negative case-control study in Japan","volume":"39","author":"Ohfuji","year":"2021","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2023.08.073_b0315","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1016\/j.vaccine.2011.10.089","article-title":"Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance","volume":"30","author":"Nilsson","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.073_b0320","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.vaccine.2021.11.078","article-title":"Epidemiology of pertussis in Costa Rica and the impact of vaccination: a 58-year experience (1961\u20132018)","volume":"40","author":"Avila-Aguero","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.073_b0325","doi-asserted-by":"crossref","DOI":"10.33321\/cdi.2022.46.3","article-title":"Australian vaccine preventable disease epidemiological review series: Pertussis, 2013\u20132018","volume":"46","author":"Marshall","year":"2022","journal-title":"Commun Dis Intell"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.073_b0330","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/03007995.2019.1662232","article-title":"Epidemiology and disease burden of pertussis in the United States among individuals aged 0\u201364 over a 10-year period (2006\u20132015)","volume":"36","author":"Tong","year":"2020","journal-title":"Curr Med Res Opin"},{"issue":"14","key":"10.1016\/j.vaccine.2023.08.073_b0335","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.vaccine.2018.02.047","article-title":"Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: the NSW Public Health Network case-control study","volume":"36","author":"Saul","year":"2018","journal-title":"Vaccine"},{"issue":"44","key":"10.1016\/j.vaccine.2023.08.073_b0340","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1016\/j.vaccine.2022.09.054","article-title":"Effectiveness of pertussis vaccination in pregnancy to prevent hospitalisation in infants aged <2 months and effectiveness of both primary vaccination and mother's vaccination in pregnancy in infants aged 2\u201311 months","volume":"40","author":"Merdrignac","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.073_b0345","doi-asserted-by":"crossref","unstructured":"Bhagat DSM, Huang G, Domingo Francesca R, Squires Susan G, Salvadori Marina I, et al. Pertussis epidemiology in Canada, 2005-2019. Canada Commun Dis Rep\u00a0=\u00a0Releve des maladies transmissibles au Canada 2023;49(1):21\u20138.","DOI":"10.14745\/ccdr.v49i01a05"},{"issue":"7","key":"10.1016\/j.vaccine.2023.08.073_b0350","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jamapediatrics.2017.0638","article-title":"The influence of maternally derived antibody and infant age at vaccination on infant vaccine responses: an individual participant meta-analysis","volume":"171","author":"Voysey","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"44","key":"10.1016\/j.vaccine.2023.08.073_b0355","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1016\/j.vaccine.2021.09.022","article-title":"Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: individual-participant data meta-analysis","volume":"39","author":"Abu-Raya","year":"2021","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.08.073_b0360","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1473-3099(18)30717-5","article-title":"Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial","volume":"19","author":"Barug","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"46","key":"10.1016\/j.vaccine.2023.08.073_b0365","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1016\/j.vaccine.2022.09.087","article-title":"Effectiveness of maternal pertussis vaccination in Singapore: a test-negative case-control study","volume":"40","author":"Chong","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.073_b0370","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2022.5689","article-title":"US infant pertussis incidence trends before and after implementation of the maternal tetanus, diphtheria, and pertussis vaccine","author":"Skoff","year":"2023","journal-title":"JAMA Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.073_b0375","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1542\/peds.2005-2746","article-title":"Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age","volume":"118","author":"Gustafsson","year":"2006","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.vaccine.2023.08.073_b0380","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/INF.0000000000000739","article-title":"Monitoring the impact of vaccination on pertussis in infants using an active hospital-based pediatric surveillance network results from 17 years' experience, 1996\u20132012, France","volume":"34","author":"Tubiana","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2023.08.073_b0385","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.vaccine.2005.09.019","article-title":"The impact of pre-school booster vaccination of 4-6-year-old children on pertussis in 0-1-year-old children","volume":"24","author":"Hviid","year":"2006","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2023.08.073_b0390","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.vaccine.2022.04.038","article-title":"Pertussis epidemiology including direct and indirect effects of the childhood pertussis booster vaccinations, Norway, 1998\u20132019","volume":"40","author":"Seppala","year":"2022","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.073_b0395","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.vaccine.2011.11.065","article-title":"Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine","volume":"30","author":"Lavine","year":"2012","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2023.08.073_b0400","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.vaccine.2011.01.021","article-title":"Pertussis after end of a mass vaccination project-end of the \u201cvaccination honey-moon\u201d","volume":"29","author":"Trollfors","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.073_b0405","doi-asserted-by":"crossref","first-page":"E179","DOI":"10.33321\/cdi.2014.38.34","article-title":"Australian vaccine preventable disease epidemiological review series: pertussis, 2006\u20132012","volume":"38","author":"Pillsbury","year":"2014","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.vaccine.2023.08.073_b0410","unstructured":"Centers for Disease Control and Prevention. Pertussis--United States, 2001-2003. MMWR Morb Mortal Wkly Rep 2005;54(50):1283\u20136."},{"key":"10.1016\/j.vaccine.2023.08.073_b0415","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-016-0665-8","article-title":"Investigating the pertussis resurgence in England and Wales, and options for future control","volume":"14","author":"Choi","year":"2016","journal-title":"BMC Med"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2023.08.073_b0420","first-page":"48","article-title":"The changing epidemiology of pertussis in the Hunter New England area and potential implications for the immunisation schedule","volume":"17","author":"Durrheim","year":"2006","journal-title":"N S W Public Health Bull"},{"key":"10.1016\/j.vaccine.2023.08.073_b0425","doi-asserted-by":"crossref","unstructured":"Viney KA, McAnulty JM, Campbell-Lloyd S. EPIREVIEW. Pertussis in New South Wales, 1993-2005: the impact of vaccination policy on pertussis epidemiology. N S W Public Health Bull 2007;18(3\u20134):55\u201361.","DOI":"10.1071\/NB07068"},{"issue":"32","key":"10.1016\/j.vaccine.2023.08.073_b0430","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2807\/1560-7917.ES2014.19.32.20875","article-title":"Increase of pertussis incidence in 2010 to 2012 after 12 years of low circulation in Spain","volume":"19","author":"Sizaire","year":"2014","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2023.08.073_b0435","doi-asserted-by":"crossref","unstructured":"Smith T, Rotondo J, Desai S, Deehan H. Pertussis surveillance in Canada: trends to 2012. Canada Commun Dis Rep\u00a0=\u00a0Releve des maladies transmissibles au Canada 2014;40(3):21\u201330.","DOI":"10.14745\/ccdr.v40i03a01"},{"issue":"2","key":"10.1016\/j.vaccine.2023.08.073_b0440","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.vaccine.2010.10.058","article-title":"The impact of additional pertussis vaccine doses on disease incidence in children and infants","volume":"29","author":"Stein-Zamir","year":"2010","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.vaccine.2023.08.073_b0445","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1016\/j.vaccine.2013.07.060","article-title":"Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?","volume":"31","author":"van der Maas","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.08.073_b0450","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1142\/S0218339022500280","article-title":"An age-structured model for pertussis transmission with multiple infections studying the effects of childhood DTAP and adolescent TDAP vaccines","volume":"30","author":"Han","year":"2022","journal-title":"J Biol Syst"},{"key":"10.1016\/j.vaccine.2023.08.073_b0455","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268819000761","article-title":"On the role of different age groups during pertussis epidemics in California, 2010 and 2014","volume":"147","author":"Mahmud","year":"2019","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2023.08.073_b0460","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijid.2019.10.027","article-title":"Impact of Pertussis on the Italian population: analysis of hospital discharge records in the period 2001\u20132014","volume":"91","author":"Brosio","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2023.08.073_b0465","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1111\/apa.15800","article-title":"Pertussis in infants in Nordic countries","volume":"110","author":"Bhavsar","year":"2021","journal-title":"Acta Paediatr"},{"issue":"15","key":"10.1016\/j.vaccine.2023.08.073_b0470","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.vaccine.2008.01.045","article-title":"Re-emergence of pertussis in Slovenia: time to change immunization policy","volume":"26","author":"Grgic-Vitek","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.08.073_b0475","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpediatrics.2011.1093","article-title":"Early impact of the US Tdap vaccination program on pertussis trends","volume":"166","author":"Skoff","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"7","key":"10.1016\/j.vaccine.2023.08.073_b0480","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1001\/archpediatrics.2011.85","article-title":"Infant pertussis epidemiology and implications for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) Vaccination King County, Washington, 2002 through 2007","volume":"165","author":"Hanson","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.073_b0485","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eimc.2013.09.013","article-title":"Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine","volume":"33","author":"Sala-Farre","year":"2015","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.vaccine.2023.08.073_b0490","first-page":"6","article-title":"Evaluation of enhanced follow-up for pertussis in children aged 5\u20139 years in Sydney Local Health District","volume":"43","author":"Cavanagh","year":"2019","journal-title":"NSW Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2023.08.073_b0495","doi-asserted-by":"crossref","unstructured":"Guiso N, Liese J, Plotkin S. The global pertussis initiative: Meeting report from the fourth regional roundtable meeting, France, April 14\u201315, 2010 - Commentary. Hum Vacc 2011;7(4).","DOI":"10.4161\/hv.7.4.14528"},{"issue":"6","key":"10.1016\/j.vaccine.2023.08.073_b0500","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00431-013-2228-8","article-title":"Incidence of whooping cough in Spain (1997\u20132010): an underreported disease","volume":"173","author":"Fernandez-Cano","year":"2014","journal-title":"Eur J Pediatr"},{"issue":"8","key":"10.1016\/j.vaccine.2023.08.073_b0505","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00006454-200208000-00013","article-title":"Pediatric sentinel surveillance of vaccine-preventable diseases in Italy","volume":"21","author":"Atti","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2023.08.073_b0510","doi-asserted-by":"crossref","unstructured":"Chambers C, Skowronski DM, Hoang L, Li HG, Fritz CE, Gustafson R, et al. Pertussis surveillance trends in British Columbia, Canada, over a 20-year period: 1993\u20132013. Canada Commun Dis Rep\u00a0=\u00a0Releve des maladies transmissibles au Canada 2014;40(3):31\u201341.","DOI":"10.14745\/ccdr.v40i03a02"},{"issue":"25","key":"10.1016\/j.vaccine.2023.08.073_b0515","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1016\/j.vaccine.2011.03.065","article-title":"Epidemiology of pertussis in a country with high vaccination coverage","volume":"29","author":"Crespo","year":"2011","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.vaccine.2023.08.073_b0520","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2807\/1560-7917.ES.2016.21.36.30334","article-title":"Epidemiology of pertussis in Denmark, 1995 to 2013","volume":"21","author":"Dalby","year":"2016","journal-title":"Eurosurveillance"},{"issue":"20","key":"10.1016\/j.vaccine.2023.08.073_b0525","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.2012.14939","article-title":"Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010","volume":"308","author":"Misegades","year":"2012","journal-title":"Jama-J Am Med Assoc"},{"issue":"1332","key":"10.1016\/j.vaccine.2023.08.073_b0530","first-page":"52","article-title":"Pertussis (whooping cough) epidemiology in Waikato, New Zealand: 2000\u20132009","volume":"124","author":"Wall","year":"2011","journal-title":"N Z Med J"},{"key":"10.1016\/j.vaccine.2023.08.073_b0535","unstructured":"World Health Organisation SAGE. Pertussis working group Background paper SAGE April 2014; 2014."},{"issue":"3","key":"10.1016\/j.vaccine.2023.08.073_b0540","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2021-323055","article-title":"Waning infant pertussis during COVID-19 pandemic","volume":"107","author":"Falkenstein-Hagander","year":"2022","journal-title":"Arch Dis Child"},{"issue":"27","key":"10.1016\/j.vaccine.2023.08.073_b0545","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1016\/j.vaccine.2022.04.086","article-title":"Decay of anti-Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measures","volume":"40","author":"Reicherz","year":"2022","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2023.08.073_b0550","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1016\/j.vaccine.2022.10.020","article-title":"The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: a cross-sectional sero-epidemiological study","volume":"40","author":"He","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.08.073_b0555","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-022-12830-9","article-title":"Impact of the COVID-19 pandemic on Bordetella pertussis infections in England","volume":"22","author":"Tessier","year":"2022","journal-title":"BMC Public Health"},{"issue":"11","key":"10.1016\/j.vaccine.2023.08.073_b0560","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1093\/cid\/ciab333","article-title":"Estimating population-level effects of the acellular pertussis vaccine using routinely collected immunization data","volume":"73","author":"Rane","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2301037X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2301037X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:31:41Z","timestamp":1759404701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2301037X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":112,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0264410X2301037X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.073","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pertussis immunisation strategies to optimise infant pertussis control: A narrative systematic review","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}